CHARMed collaboration creates a potent therapy candidate for fatal prion diseases
A new gene-silencing tool shows promise as a future therapy against prion diseases and paves the way for new approaches to treating disease.
A new gene-silencing tool shows promise as a future therapy against prion diseases and paves the way for new approaches to treating disease.
Known for her rigorous approach to science and her influential research, Pardue paved the way for women in science at MIT and beyond.
With their “T-REX” method, DNA embedded in the polymer could be used for long-term storage of genomes or digital data such as photos and music.
By capturing short-lived RNA molecules, scientists can map relationships between genes and the regulatory elements that control them.
Senior Hanjun Lee planned to pursue chemistry at MIT. A course in genetics changed that.
Alnylam Pharmaceuticals, founded by MIT professors and former postdocs, has turned the promise of RNAi research into a new class of powerful therapies.
Single-cell gene expression patterns in the brain, and evidence from follow-up experiments, reveal many shared cellular and molecular similarities that could be targeted for potential treatment.
Researchers also found that a variant of the protein is not as protective against the bacteria and increases susceptibility to the disease.
With the new technique, MIT researchers hope to identify mutations that could be targeted with new cancer therapies.
A new study finds precancerous colon cells turn on a gene called SOX17, which helps them evade detection and develop into more advanced tumors.
MIT researchers can now track a cell’s RNA expression to investigate long-term processes like cancer progression or embryonic development.
By analyzing bacterial data, researchers have discovered thousands of rare new CRISPR systems that have a range of functions and could enable gene editing, diagnostics, and more.
MIT study suggests 3D folding of the genome is key to cells’ ability to store and pass on “memories” of which genes they should express.
MIT computer scientists developed a way to calculate polygenic scores that makes them more accurate for people across diverse ancestries.
New research finds RNA-guided enzymes called Fanzors are widespread among eukaryotic organisms.